Table of Contents
What changed
Revenue rose 16.7% to NZ$409.7m, PBT rose 29.5% to NZ$45.4m, and NPAT rose 24.9% to NZ$32.0m. Operating cash flow of NZ$68.0m against capex of NZ$14.8m produced pre-lease free cash flow of NZ$53.2m, equivalent to 166.4% of NPAT. Gross margin eased to 57.3% from 57.6%, a 26bps contraction despite the strong top-line. Inventory fell 7.3% to NZ$31.0m and inventory days improved sharply to 64.7 from 81.9. The balance sheet strengthened, with total liabilities down 7.4% to NZ$106.2m and equity up 6.5% to NZ$96.3m, even as cash held on balance sheet slipped slightly to NZ$32.5m. The final dividend is unchanged at 24.0 cents per share.
What matters
- Second-half weakness is the dominant read. HY23 contributed 54.5% of full-year revenue but 65.1% of full-year NPAT. That implies H2 revenue of NZ$186.4m (down on H1's NZ$223.3m) and, more tellingly, H2 NPAT of just NZ$11.2m versus H1's NZ$20.8m. The headline full-year growth rate masks a clear earnings deceleration into the back half.
- Segment mix risk is concentrated in Australia. Glassons Australia is now 46.7% of group revenue at an inferred segment margin of ~12.9%, compared with Glassons NZ at ~13.5% and Hallensteins at just ~5.1%. Group profit is increasingly geared to one banner in a foreign currency, with no quantified FX sensitivity disclosed.
- Cash quality and returns are genuinely strong. ROE improved to 34.2% from 28.5%, pre-lease FCF covers the declared dividend (payout ratio 26.9% of FCF, 44.8% of NPAT), and the inventory unwind assisted cash generation without triggering the margin collapse that normally accompanies a clearance cycle.
Expectations
No stated targets, forward-work disclosure, or formal guidance were provided in the release. The only shape context is internal: the HY23 split shows an unambiguously front-loaded year. Taking H2 as the most recent run-rate, implied H2 NPAT of NZ$11.2m annualises well below the FY23 print of NZ$32.0m. The release does not contain trading-update language or an explicit outlook statement that would let a reader judge whether that H2 trajectory has stabilised, improved, or continued to soften into the new period.
Quality of result
The earnings result is clean at the tax line. The effective tax rate moved to 29.6% from 27.0%, which is enough to explain why NPAT growth (24.9%) lagged PBT growth (29.5%) without invoking unusual items — PBT is the cleaner operating read here. Gross margin contracted only modestly and there are no disclosed non-recurring items or non-GAAP adjustments, so the reported operating improvement looks statutory. Cash conversion is strong and partially working-capital-assisted: the NZ$2.4m inventory drawdown and the 17-day reduction in inventory days contributed to the NZ$53.2m pre-lease FCF, but the magnitude of FCF (166% of NPAT) is too large to be attributed to working capital alone. The main quality caveat is not accounting-based — it is the intra-year shape, which suggests the FY23 profit number is not a reliable run-rate.
Unresolved
- What drove the H2 step-down in NPAT from NZ$20.8m to NZ$11.2m — category mix, Australian trading conditions, markdowns, or cost inflation?
- Prior-year operating cash flow and capex are not in the structured data, so the year-on-year change in cash conversion cannot be quantified.
- Net debt, gross borrowings and any lease liability movement are not disclosed, so leverage direction is qualitative only.
- FX sensitivity on the 46.7% Australian revenue exposure is not quantified, and no hedging policy detail is provided.
- With no customer, channel, or online/store split in the extracts, the durability of the Glassons Australia margin cannot be interrogated.
This briefing cannot assess current trading since balance date or any post-period trading update that may sit outside the supplied extracts.
Key metrics
| Metric | FY23 | FY22 | Change |
|---|---|---|---|
| Revenue | $409.7m | $351.2m | +16.7% ↑ |
| Net profit after tax | $32.0m | $25.6m | +24.9% ↑ |
| Net cash inflow from operating activities | $68.0m | — | — |
| Final dividend per share | 24.0c | 24.0c | flat |
| Profit before tax | $45.4m | $35.1m | +29.5% ↑ |
| Cash and cash equivalents | $32.5m | $0.0m | +955135.3% ↑ |
| Total assets | $202.6m | $205.2m | -1.3% ↓ |
Reference: annolyse.ai/briefings/hlg-fy23
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Glassons New Zealand | $112.4m | — | $15.1m | n/a |
| Glassons Australia | $191.2m | — | $24.6m | n/a |
| Hallensteins | $106.0m | — | $5.4m | n/a |
| Property | $0m | — | $0.3m | n/a |
Reference: annolyse.ai/briefings/hlg-fy23
Analytical metrics
| Metric | FY23 | FY22 | Context |
|---|---|---|---|
| PBT growth | +29.5% | — | — |
| Effective tax rate | 29.6% | 27.0% | — |
| FCF pre-lease | $53.2m | — | — |
| FCF / NPAT | 166.4% | — | complementary conversion metric |
| Capex % revenue | 3.6% | — | — |
| Capex | $14.8m | — | — |
| Debtor days | 0.3 | 0.5 | -0.2 days |
| Inventory days | 64.7 | 81.9 | -17.2 days |
| Trade debtors | $0.3m | $0.5m | −$0.1m |
| Payout ratio vs NPAT | 44.8% | — | — |
| Payout ratio vs FCF pre-lease | 26.9% | — | covered |
| ROE (annualised) | 34.2% | 28.5% | Strengthening |
| HY23 share of FY23 revenue | 54.5% | — | Other half was 45.5% |
| HY23 share of FY23 NPAT | 65.1% | — | Other half was 34.9% |
| Profit from continuing operations | $32.0m | $25.6m | +$6.4m |
Reference: annolyse.ai/briefings/hlg-fy23
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.